Rating History for Alnylam Pharmaceuticals (ALNY) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/28/2026 | Eliana Merle | New Coverage | Overweight (N/A) |
527.00 (N/A) |
361.35 (320.66) |
-11.26% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
